Agilent Technologies, Inc. $A Shares Sold by Boston Trust Walden Corp

Boston Trust Walden Corp lowered its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 3.0% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 187,730 shares of the medical research company’s stock after selling 5,707 shares during the period. Boston Trust Walden Corp owned about 0.07% of Agilent Technologies worth $24,936,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of A. Fiduciary Trust Co boosted its holdings in Agilent Technologies by 1.6% in the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock worth $633,000 after buying an additional 77 shares during the last quarter. Freestone Capital Holdings LLC increased its stake in Agilent Technologies by 2.0% during the 4th quarter. Freestone Capital Holdings LLC now owns 4,218 shares of the medical research company’s stock worth $574,000 after buying an additional 84 shares in the last quarter. Sapient Capital LLC raised its holdings in shares of Agilent Technologies by 4.2% during the first quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company’s stock valued at $240,000 after acquiring an additional 85 shares during the last quarter. Plan A Wealth LLC lifted its position in shares of Agilent Technologies by 3.2% in the fourth quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company’s stock valued at $403,000 after acquiring an additional 92 shares in the last quarter. Finally, IHT Wealth Management LLC lifted its position in shares of Agilent Technologies by 4.9% in the fourth quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company’s stock valued at $278,000 after acquiring an additional 96 shares in the last quarter.

Analysts Set New Price Targets

A has been the subject of several recent research reports. Sanford C. Bernstein initiated coverage on Agilent Technologies in a research note on Friday, June 26th. They issued an “outperform” rating and a $155.00 price objective for the company. Wolfe Research reaffirmed a “hold” rating on shares of Agilent Technologies in a research note on Tuesday, June 2nd. HSBC dropped their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Robert W. Baird raised their price target on shares of Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 26th. Finally, Weiss Ratings upgraded shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, June 2nd. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, Agilent Technologies currently has an average rating of “Moderate Buy” and an average price target of $160.24.

Agilent Technologies Stock Performance

NYSE A opened at $149.33 on Friday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. The stock’s fifty day moving average is $135.12 and its two-hundred day moving average is $125.40. The firm has a market capitalization of $42.18 billion, a P/E ratio of 29.99, a price-to-earnings-growth ratio of 2.62 and a beta of 1.25. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.27.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. The business had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same period last year, the company earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, research analysts anticipate that Agilent Technologies, Inc. will post 6.03 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were paid a dividend of $0.255 per share. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s payout ratio is 20.48%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.